Aβ Amyloid Fibrils Possess a Core Structure Highly Resistant to Hydrogen Exchange

We describe here experiments designed to characterize the secondary structure of amyloid fibrils of the Alzheimer's amyloid plaque peptide Aβ, using hydrogen-deuterium exchange measurements evaluated by mass spectrometry. The results show that ≈50% of the amide protons of the polypeptide backbo...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 97; no. 25; pp. 13597 - 13601
Main Authors: Kheterpal, Indu, Zhou, Shaolian, Cook, Kelsey D., Wetzel, Ronald
Format: Journal Article
Language:English
Published: National Academy of Sciences of the United States of America 05-12-2000
National Acad Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe here experiments designed to characterize the secondary structure of amyloid fibrils of the Alzheimer's amyloid plaque peptide Aβ, using hydrogen-deuterium exchange measurements evaluated by mass spectrometry. The results show that ≈50% of the amide protons of the polypeptide backbone of Aβ(1-40) resist exchange in aqueous, neutral pH buffer even after more than 1,000 h of incubation at room temperature. We attribute this extensive, strong protection to H-bonding by residues in core regions of β-sheet structure within the fibril. The backbone amide hydrogens exchange at variable rates, suggesting different degrees of protection within the fibril. These data suggest that it is unlikely that the entire Aβ sequence is involved in H-bonded secondary structure within the amyloid fibril. Future studies using the methods described here should reveal further details of Aβ fibril structure and assembly. These methods also should be amenable to studies of other amyloid fibrils and protein aggregates.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Present address: Covance Laboratories, Inc., P.O. Box 7545, Madison, WI 53707-7545.
Edited by S. Walter Englander, University of Pennsylvania School of Medicine, Swarthmore, PA, and approved October 3, 2000
To whom reprint requests should be addressed. E-mail: rwetzel@mc.utmck.edu.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.250288897